954 related articles for article (PubMed ID: 25900159)
1. Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study.
Tumbarello M; Trecarichi EM; De Rosa FG; Giannella M; Giacobbe DR; Bassetti M; Losito AR; Bartoletti M; Del Bono V; Corcione S; Maiuro G; Tedeschi S; Celani L; Cardellino CS; Spanu T; Marchese A; Ambretti S; Cauda R; Viscoli C; Viale P;
J Antimicrob Chemother; 2015 Jul; 70(7):2133-43. PubMed ID: 25900159
[TBL] [Abstract][Full Text] [Related]
2. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy.
Tumbarello M; Viale P; Viscoli C; Trecarichi EM; Tumietto F; Marchese A; Spanu T; Ambretti S; Ginocchio F; Cristini F; Losito AR; Tedeschi S; Cauda R; Bassetti M
Clin Infect Dis; 2012 Oct; 55(7):943-50. PubMed ID: 22752516
[TBL] [Abstract][Full Text] [Related]
3. Predictors of outcome in ICU patients with septic shock caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.
Falcone M; Russo A; Iacovelli A; Restuccia G; Ceccarelli G; Giordano A; Farcomeni A; Morelli A; Venditti M
Clin Microbiol Infect; 2016 May; 22(5):444-50. PubMed ID: 26850826
[TBL] [Abstract][Full Text] [Related]
4. Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment.
Zarkotou O; Pournaras S; Tselioti P; Dragoumanos V; Pitiriga V; Ranellou K; Prekates A; Themeli-Digalaki K; Tsakris A
Clin Microbiol Infect; 2011 Dec; 17(12):1798-803. PubMed ID: 21595793
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for infection and predictors of mortality among patients with KPC-producing Klebsiella pneumoniae bloodstream infections in the intensive care unit.
Papadimitriou-Olivgeris M; Marangos M; Christofidou M; Fligou F; Bartzavali C; Panteli ES; Vamvakopoulou S; Filos KS; Anastassiou ED
Scand J Infect Dis; 2014 Sep; 46(9):642-8. PubMed ID: 25017796
[TBL] [Abstract][Full Text] [Related]
6. Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes.
Mouloudi E; Protonotariou E; Zagorianou A; Iosifidis E; Karapanagiotou A; Giasnetsova T; Tsioka A; Roilides E; Sofianou D; Gritsi-Gerogianni N
Infect Control Hosp Epidemiol; 2010 Dec; 31(12):1250-6. PubMed ID: 20973725
[TBL] [Abstract][Full Text] [Related]
7. Clinical and epidemiological characteristics of KPC-producing Klebsiella pneumoniae from bloodstream infections in a tertiary referral center in Italy.
Brescini L; Morroni G; Valeriani C; Castelletti S; Mingoia M; Simoni S; Masucci A; Montalti R; Vivarelli M; Giacometti A; Barchiesi F
BMC Infect Dis; 2019 Jul; 19(1):611. PubMed ID: 31299943
[TBL] [Abstract][Full Text] [Related]
8. Risk factors and outcome of infections with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in kidney transplant recipients.
Freire MP; Abdala E; Moura ML; de Paula FJ; Spadão F; Caiaffa-Filho HH; David-Neto E; Nahas WC; Pierrotti LC
Infection; 2015 Jun; 43(3):315-23. PubMed ID: 25690848
[TBL] [Abstract][Full Text] [Related]
9. Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae.
Falcone M; Bassetti M; Tiseo G; Giordano C; Nencini E; Russo A; Graziano E; Tagliaferri E; Leonildi A; Barnini S; Farcomeni A; Menichetti F
Crit Care; 2020 Jan; 24(1):29. PubMed ID: 32000834
[TBL] [Abstract][Full Text] [Related]
10. Carbapenemase-producing Klebsiella pneumoniae bloodstream infection in critically ill patients: risk factors and predictors of mortality.
Papadimitriou-Olivgeris M; Fligou F; Bartzavali C; Zotou A; Spyropoulou A; Koutsileou K; Vamvakopoulou S; Sioulas N; Karamouzos V; Anastassiou ED; Spiliopoulou I; Christofidou M; Marangos M
Eur J Clin Microbiol Infect Dis; 2017 Jul; 36(7):1125-1131. PubMed ID: 28102514
[TBL] [Abstract][Full Text] [Related]
11. Outbreaks of colistin-resistant and colistin-susceptible KPC-producing Klebsiella pneumoniae in a Brazilian intensive care unit.
Rossi Gonçalves I; Ferreira ML; Araujo BF; Campos PA; Royer S; Batistão DW; Souza LP; Brito CS; Urzedo JE; Gontijo-Filho PP; Ribas RM
J Hosp Infect; 2016 Dec; 94(4):322-329. PubMed ID: 27654515
[TBL] [Abstract][Full Text] [Related]
12. An outbreak of infection due to beta-Lactamase Klebsiella pneumoniae Carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes.
Souli M; Galani I; Antoniadou A; Papadomichelakis E; Poulakou G; Panagea T; Vourli S; Zerva L; Armaganidis A; Kanellakopoulou K; Giamarellou H
Clin Infect Dis; 2010 Feb; 50(3):364-73. PubMed ID: 20041768
[TBL] [Abstract][Full Text] [Related]
13. Carbapenemase-producing Klebsiella pneumoniae bloodstream infections in neutropenic patients with haematological malignancies or aplastic anaemia: Analysis of 50 cases.
Tofas P; Skiada A; Angelopoulou M; Sipsas N; Pavlopoulou I; Tsaousi S; Pagoni M; Kotsopoulou M; Perlorentzou S; Antoniadou A; Pirounaki M; Skoutelis A; Daikos GL
Int J Antimicrob Agents; 2016 Apr; 47(4):335-9. PubMed ID: 27005460
[TBL] [Abstract][Full Text] [Related]
14. Mortality Associated with Bacteremia Due to Colistin-Resistant Klebsiella pneumoniae with High-Level Meropenem Resistance: Importance of Combination Therapy without Colistin and Carbapenems.
Machuca I; Gutiérrez-Gutiérrez B; Gracia-Ahufinger I; Rivera Espinar F; Cano Á; Guzmán-Puche J; Pérez-Nadales E; Natera C; Rodríguez M; León R; Castón JJ; Rodríguez-López F; Rodríguez-Baño J; Torre-Cisneros J
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559247
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity and post-antibiotic effects of colistin in combination with other antimicrobials against colistin-resistant KPC-producing Klebsiella pneumoniae bloodstream isolates.
Gaibani P; Lombardo D; Lewis RE; Mercuri M; Bonora S; Landini MP; Ambretti S
J Antimicrob Chemother; 2014 Jul; 69(7):1856-65. PubMed ID: 24648503
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Septic Shock Due to Multidrug-Resistant Acinetobacter baumannii or Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Intensive Care Unit Patients.
Russo A; Giuliano S; Ceccarelli G; Alessandri F; Giordano A; Brunetti G; Venditti M
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29555630
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy with polymyxin B for carbapenemase-producing Klebsiella pneumoniae bloodstream infection.
Medeiros GS; Rigatto MH; Falci DR; Zavascki AP
Int J Antimicrob Agents; 2019 Feb; 53(2):152-157. PubMed ID: 30722960
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study.
Giannella M; Trecarichi EM; De Rosa FG; Del Bono V; Bassetti M; Lewis RE; Losito AR; Corcione S; Saffioti C; Bartoletti M; Maiuro G; Cardellino CS; Tedeschi S; Cauda R; Viscoli C; Viale P; Tumbarello M
Clin Microbiol Infect; 2014 Dec; 20(12):1357-62. PubMed ID: 24980276
[TBL] [Abstract][Full Text] [Related]
19. Prognosis of urinary tract infection caused by KPC-producing Klebsiella pneumoniae: The impact of inappropriate empirical treatment.
Rodriguez-Gómez J; Pérez-Nadales E; Gutiérrez-Gutiérrez B; Machuca I; Martinez-Martinez L; Rivera F; Cano A; Castón JJ; Robles JC; de la Fuente C; Rodríguez-López F; Rodriguez-Baño J; Torre-Cisneros J;
J Infect; 2019 Sep; 79(3):245-252. PubMed ID: 31276705
[TBL] [Abstract][Full Text] [Related]
20. Clinical features of patients with carbapenem nonsusceptible Klebsiella pneumoniae and Escherichia coli in intensive care units: a nationwide multicenter study in Taiwan.
Chang YY; Chuang YC; Siu LK; Wu TL; Lin JC; Lu PL; Wang JT; Wang LS; Lin YT; Huang LJ; Fung CP
J Microbiol Immunol Infect; 2015 Apr; 48(2):219-25. PubMed ID: 25074627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]